EWMA document: Debridement: An updated overview and clarification of the principle role of debridement

Journal of Wound Care

Volumn 22, Issue , 2013, Pages S1-S49

  Strohal, R ^a   Dissemond, J ^b   Jordan O'Brien, J ^c   Piaggesi, A ^d   Rimdeika, R ^e,f   Young, T ^g   Apelqvist, J ^h  

^a Department of Dermatology   (Austria)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c BEAUMONT HOSPITAL   (Ireland)

^d UNIVERSITY OF PISA   (Italy)

^e KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

^f LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^g BANGOR UNIVERSITY   (United Kingdom)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876553843     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2013.22.Sup1.S1     Document Type: Article

References (155)

1. Hinchliffe, R.J., Valk, G.D., Apelqvist, J. et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008; 24 (Suppl. 1): 119-144.
2. O'Brien, M. Exploring methods of wound debridement. Br J Comm Nurs. 2002; 7: 10-18.
3. Oxford English Dictionary. Available from: http://oxforddictionaries.com/
4. Gethin, G., Cowman, S., Kolbach, D.N. Debridement for venous leg ulcers. Cochrane Database Sys Rev. 2010; 7: CD008599.
5. Vowden, K.R., Vowden, P. Wound debridement. Part 2: sharp techniques. J Wound Care. 1999; 8: 291-294.
6. Department of Health (DH). Reference guide to consent for examination or treatment. DH, 2001.
7. Fisher-Jeffes, L.F., Barton, C., Finlay, F. Clinicians' knowledge of informed consent. J Med Ethics. 2007; 33: 181-184.
8. Department of Health (DH). Seeking consent: working with children. DH, 2001.
9. Pape, T. Legal and ethical considerations of informed consent. AORN J. 1997; 65: 122-127.
10. Kanerva, A., Suominen, T., Leino-Kilpi, H. Informed consent for short stay surgery. Nurs Ethics. 1999; 6: 483-493.
11. Fisher, F., McDonald, N.J., Weston, R. Medical Ethics Today: Its practice and Philosophy. Latimer Trend, 1995.
12. Victorian Healthcare Association (VHA). Informed Consent for Treatment/Intervention VHA Clinical Governance in Community Health Discussion Paper, 2009.
13. Leclercq, W.K., Keulers, B.J., Scheltinga, M.R. et al. A review of surgical informed consent: past, present, and future. A quest to help patients make better decisions. World J Surg. 2010; 34: 1406-1415.
14. Rodeheaver, G.T. Pressure ulcer debridement and cleansing: a review of current literature. Ostomy Wound Manage. 1999; 45 (Suppl. 1A): 80S-85S.
15. Eneroth, M., van Houtum, W.H. The value of debridement and vacuum-assisted closure (V.A.C.) therapy in diabetic foot ulcers. Diabetes Metab Res Rev. 2008; 24 (Suppl. 1): S76-80.
16. Armstrong, M., Price, P. Wet-todry gauze dressings: fact and fiction Wounds. 2004; 16: 56-62.
17. Kammerlander, G., Andriessen, A., Asmussen, P. et al. Role of the wet-to-dry phase of cleansing in preparing the chronic wound bed for dressing application. J Wound Care. 2005; 14: 349-353.
18. Ovington, L.G. Hanging wet-to-dry dressings out to dry. Home Healthc Nurse. 2001; 19: 477-484.
19. Spoelhof, G.D., Ide, K. Pressure ulcers in nursing home patients. Am Fam Physician. 1993; Vol 47: 1207-1215.
20. Nash, M.S., Nash, L.H., Garcia, R.G., Neimark, P. Nonselective debridement and antimicrobial cleansing of a venting ductal breast carcinoma. Arch Phys Med Rehabil. 1999; 80: 118-121.
21. Donati, L., Vigano, M. Use of the hydrocolloidal dressing Duoderm for skin donor sites for burns. Int J Tissue React. 1988; 4: 267-272.
22. Barnea, Y., Amir, A., Leshem, D. et al. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment, Ann Plast Surg. 2004; 53: 132-136.
23. Dryburgh, N., Smith, F., Donaldson, J., Mitchell, M. Debridement for surgical wounds. Cochrane Database Syst Rev. 2008; 3, CD006214.
24. Edwards, J., Stapley, S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010; 1, CD003556.
25. Vermeulen, H., Ubbink, D.T., Goossens, A.et al. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev. 2004; 1, CD003554.
26. Ragnarson Tennvall, G., Apelqvist, J. Cost-effective management of diabetic foot ulcers: a review. Pharmacoeconomics. 1997; 12: 42-53.
27. Lewis, R., Whiting, P., ter Riet, G., et al. A rapid and systematic review of the clinical effectiveness and cost effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess. 2001; 5: 1-141.
28. Benbow, M. Using debrisoft for wound debridement. J Comm Nurs. 2001; 25: 5, 17-18.
29. Haemmerle, G., Duelli, H., Abel, M., Strohal, R. The wound debrider: a new monofilament fibre technology. Br J Nurs. 2011; 20: 6 (Suppl.), S35-42.
30. Dam, W., Winther, C., Rasmussen, G.S. Methods for cleaning and debridement of wounds - experiences with Debrisoft. SAR. 2011; 19: 182-184.
31. Vowden, K., Vowden, P. Debrisoft: Revolutionising debridement. Br J Nurs. 2011; 20: 20 (Suppl.), S1-S16.
32. Bahr, S., Mustafi, N., Hättig, P. et al. Clinical efficacy of a new monofilament fibre-containing wound debridement product. J Wound Care. 2011; 20: 242-248.
33. Gray, D., Acton, C., Chadwick, P. et al. Consensus guidance for the use of debridement techniques in the UK. Wounds UK. 2011; 7: 77-84.
34. Dissemond, J. Modern wound dressings for the therapy of chronic wounds [in German]. Hautarzt. 2006; 10: 881-887.
35. Bouza, C., Munoz, A., Amate, J.M. Efficacy of modern dressings in the treatment of leg ulcers: a systematic review. Wound Repair Regen. 2005; 13: 218-229.
36. König, M., Vanscheidt, W., Augustin, M., Kapp, H. Enzymatic versus autolytic debridement of chronic leg ulcers: A prospective randomised trial. J Wound Care. 2005; 14: 320-323.
37. Caruso, D.M., Foster, K.N., Blome-Eberwein, S.A. et al. Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J Burn Care Res. 2006; 27: 298-309.
38. Vandenbulcke, K., Horvat, L.I., De Mil, M. et al. Evaluation of the antibacterial activity and toxicity of 2 new hydrogels: a pilot study. Int J Low Extrem Wounds. 2006; 5: 109-114.
39. Jull, A.B., Rodgers, A., Walker, N. Honey as a topical treatment for wounds. Cochrane Database Syst Rev. 2008; 4, CD005083.
40. Wiegand, C., Abel, M., Ruth, P., Hipler, U.C. Comparison of the antimicrobial effect of two superabsorbent polymer-containing wound dressings in vitro. 4th International Workshop on Wound Technology (IWWT), Paris, 2012.
41. Apelqvist, J., Ragnarson Tennvall, G. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial. Acta Derm Venereol. 1996; 76: 231-235.
42. Moss, C., Taylor, A.E., Shuster, S. Comparison of cadexomer iodine and dextranomer for chronic venous ulcers. Clin Exp Dermatol. 1987; 12: 413-418.
43. SIGN (Scottish Intercollegiate Guidelines Network), Part of NHS Quality Improvement Scotland. Management of Chronic Venous Leg Ulcers - A National Clinical Guideline. SIGN, 2010.
44. Hansson, C., Persson, L.M., Stenquist, B. et al. The effects of Cadexomer iodine paste in the treatment of veneous leg ulcers compared with hydrocollid dressing and paraffin gauze dressing. Int Dermatol. 1998; 37: 390-396.
45. National Pressure Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP). Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline. NPUAP/EPUAP, 2009.
46. Yastrub, D.J. Relationship between type of treatment and degree of wound healing among institutionalized geriatric patients with stage II pressure ulcers. Care Manage J. 2004; 5: 213-218.
47. Freise, J., Kohaus, S., Körber, A. et al. Contact sensitization in patients with chronic wounds: Results of a prospective investigation. J Eur Acad Dermatol Venereol. 2008; 22: 1203-1207.
48. Bowler, P.G., Jones, S.A., Davies, B.J., Coyle, E. Infection control properties of some wound dressings. J Wound Care. 1999; 8: 499-502.
49. de la Brassinne, M., Thirion, L., Horvat, L.I. A novel method of comparing the healing properties of two hydrogels in chronic leg ulcers. J Eur Acad Dermatol Venereol. 2006; 20: 131-135.
50. Best Practice Statement: The Use of Topical Antiseptic/Antimicrobial Agents in Wound Management (2nd edn). Wounds UK, 2011.
51. Sundberg, J., Meller, R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. Wounds. 1997; 9: 68-86.
52. Falabella, A.F. Debridement and wound bed preparation. Dermatol Ther. 2006; 19: 317-325.
53. Pullen, R., Popp, R., Volkers, P., Fusgen, I. Prospective randomized double-blind study of the wound-debriding effects of collagenase and fibrinolysin/deoxyribonuclease in pressure ulcers. Age Ageing. 2002; 31: 126-130.
54. Ramundo, J., Gray, M. Collagenase for enzymatic debridement: a systematic review. J Wound Ostomy Continence Nurs. 2009; 36: 4-11.
55. Shapira, E., Giladi, A., Neiman, Z. Use of water insoluble papain for debridement of burn eschar and necrotic tissue. Plast Reconstr Surg. 2005; 52: 279.
56. Hellgren, L., Mohr, V., Vincent, J. Proteases of Antarctic krill - a new system for effective enzymatic debridement of necrotic ulcerations. Experientia. 1986; 42: 403-404.
57. Mekkes, J.R., Le Poole, I.C., Das, P.K. et al. Efficient debridement of necrotic wounds using proteolytic enzymes derived from Antarctic krill: a double-blind, placebo-controlled study in a standardized animal wound model. Wound Repair Regen. 1998; 6: 50-57.
58. Dissemond, J., Goos, M. Conditioning of chronic wounds with proteolytic enzymes [in German]. Hautarzt. 2003; 54: 1073-1079.
59. Smith, R.G. Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage. 2008; 54: 8, 16-34.
60. Goode, A.W., Glazer, G., Ellis, B.W. The cost effectiveness of Dextranomer and Eusol in the treatment of infected surgical wounds. Br J Clin Pract. 1979; 33: 325-328.
61. Heel, R.C., Marton, P., Brogden, R.N. et al. Dextranomer: a review of its general properties and therapeutic efficacy. Drugs. 1979; 18: 89-102.
62. Dissemond, J., Goos, M. Options for debridement in the therapy of chronic wounds [in German]. J Dtsch Dermatol Ges. 2004; 2: 743-751.
63. Greenwood, D. Honey for superficial wounds and ulcers. Lancet. 1993; 341: 8837, 90-91.
64. Schneider, L.A., Körber, A., Grabbe, S., Dissemond, J. Influence of pH on wound healing: a new perspective for wound therapy? Arch Dermatol Res. 2007; 298: 418-420.
65. Gethin, G., Cowman, S. Manuka honey vs. hydrogel - a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs. 2009; 18: 466-474.
66. Tartibian, B., Maleki, B.H. The effects of honey supplementation on seminal plasma cytokines, oxiditive stress biomarkers and antioxidants during 8 weeks of intensive cyclying training. J Androl. 2012; 33: 449-461.
67. Bauer, L., Kohlich, A., Hirschwehr, R. et al. Food allergy to honey: pollen or bee products? Characterization of allergenic proteins in honey by means of immunoblotting. J Allergy Clin Immunol. 1996; 97 (1 Pt 1): 65-73.
68. Horobin, A., Shakeesheff, K., Pritchard, D. Maggots and wound healing: an investigation of the effects of secretions from Lucilla sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen. 2005; 13: 422-433.
69. Baer, W.S. The treatment of chronic osteomyelitis with the maggot (larvae or blowfly) J Bone Joint Surg. 1931; 13: 428-475.
70. Margolin, L., Gialanella, P. Assessment of the antimicrobial properties of maggots. Int Wound J. 2010; 7: 202-204.
71. Sherman, R.A., Shimoda, K.J. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection. Clin Infect Dis. 2004; 39: 1067-1070.
72. Chambers, L., Woodrow, S., Brown A.P. et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia ssericata used for clinical debridement of non healing wounds. Br J Dermatol. 2003; 148: 14-23.
73. Sherman, R.A. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002; 10: 208-214.
74. Mumcuoglu, KY., Miller, J., Mumcuoglu, M. et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata. J Med Entomol. 2001; 38: 161-166.
75. Steenvoorde, P., Jukema, G.N. The antimicrobial activity of maggots in vivo results. J Tissue Viability. 2004; 14: 97-101.
76. Van der Plas, M.J.A., Jukema, G.N., Wai, S.W. et al. Maggot excretions/ secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2008; 61: 377-379.
77. Wollina, U., Liebold, K., Schmidt, W. et al. Biosurgery supports granulation and debridement in chronic wounds- clinical data and remittance spectroscopy measurement. Int Soc Dermatol. 2002; 41: 635-639.
78. Gilead, L., Mumcuoglu, K.Y., Ingher, A. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. J Wound Care. 2012; 21: 78-85.
79. Cullen, A. Spinal cord injury: using maggots to ease the pressure. Wounds UK. 2009; 5: 82-85.
80. Paul, l.A.G., Ahmad, N.W., Lee, H.L. et al. Maggot debridement therapy with Lucile cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J. 2009; 6: 39-46.
81. Rodgers, A. Maggots for the management of purpura fulminans in a paediatric patient. Wounds UK. 2009; 5: 141-145.
82. Dumville, J., Worthy, G., Bland, J.M. et al. Larval therapy for leg ulcers (VenUS 11): randomised controlled trial. BMJ. 2009; 338: b773.
83. Sherman, R.A. Maggot therapy for treating diabetic foot ulcers unresposive to conventional therapy. Diabetes Care. 2003; 26: 446-451.
84. Spilsbury, K., Cullum, N., Dumville, J. et al. Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration. Health Expect. 2008; 11: 148-159.
85. Courtenay, M., Church, J.C., Ryan, T.J. Larva therapy in wound management. J R Soc Med. 2000; 93: 72-74.
86. Markevich, Y.O., McLeod-Roberts, J., Mousley, M., Molloy, E. Maggot therapy for diabetic neuropathy foot wounds. Diabetologia. 2000; 43 (Suppl. 1): A15.
87. Bradley, M., Cullum, N., Sheldon, T. The debridement of chronic wounds: a systematic review. Health Technol Assess. 1999; 3: 17, 1-78.
88. Mumcuoglu, K.Y., Ingber, A., Gilead. L. et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol. 1999; 38: 623-627.
89. Waymen, J., Walker, A., Sowinski, A. et al. Larval debridement therapy: a cost-effective alternative to hydrogel in necrotic venous ulcers: a randomized trial. Br J Surg. 2000; 87: 507.
90. Evans, H. Larvae therapy and venous leg ulcers: reducing the 'Yuk factor'. J Wound Care. 2002; 11: 407-408.
91. Blake, F.A.S., Abromeit, N., Bubenheim, M. The biosurgical wound debridement: experimental investigation of efficiency and practicability. Wound Repair Regen. 2007; 15: 756-761.
92. Wayman, J., Anne, W., Sowinski, A., Walker, M.A. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability. 2000; 10: 91-94.
93. Drisdelle, R. Maggot debridement therapy: a living cure. Nursing. 2003; 33: 17.
94. Richardson, M. The benefit of larval therapy in wound care. Nurs Stand. 2004; 19: 7, 70-74.
95. Soares, M.O., Iglesias, C.P., Bland, M. et al. Cost effectiveness analysis of larval therapy for leg ulcers. BMJ. 2009; 338: b825.
96. Margolin, L., Gialanella, P. Assessment of the antimicrobial properties of maggots. Int Wound J. 2010; 7: 202-204.
97. Brown, L.L., Shelton, H.T., Bornside, G.H., Cohn, I., Jnr. Evaluation of wound irrigation by pulsatile jet and conventional methods. Ann Surg. 1978; 187: 170-173.
98. Granick, M.S., Tenenhaus, M., Knox, K.R., Ulm, J.P. Comparison of wound irrigation and tangential hydrodissection in bacterial clearance of contaminated wounds: results of a randomized, controlled clinical study. Ostomy Wound Manage. 2007; 53: 4, 64-70.
99. Caputo, W.J., Beggs, D.J., DeFede, J.L. et al. A prospective randomised controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J. 2008; 5: 288-294.
100. Draeger, R.W., Dahners. L.E. Traumatic wound debridement: a comparison of irrigation methods. J Orthop Trauma. 2006; 20: 83-88.
101. Gravante, G., Delogu, D., Esposito, G., Montone, A. Versajet hydrosurgery versus classic escharectomyforburndébridment: a prospective randomized trial. J Burn Care Res. 2007; 28: 720-724.
102. Bowling, F.L., Stickings, D.S., Edwards-Jones, V. et al. Hydro debridement of wounds: effectiveness in reducing wound bacterial contamination and potential for air bacterial contamination. J Foot Ankle Res. 2009; 8: 13.
103. Daeschlein, G., Lehnert, W., Arnold, A. et al. Hygienic safety of a new hydrodynamic wound debridement system. Dermatol Surg. 2010; 36: 1426-1438.
104. Nussbaum, E.L., Biemann, I., Mustard, B. Comparison of ultrasound/ultraviolet-C and laser for treatment of pressure ulcers in patients with spinal cord injury. Phys Ther. 1994; 74: 812-825.
105. Herberger, K., Franzke, N., Blome, C. et al. Efficacy, tolerability and patient benefit of ultrasound-assisted wound treatment versus surgical debridement: a randomized clinical study. Dermatol. 2011; 222: 244-249.
106. Morykwas, M.J., Argenta, L.C., Shelton-Brown, E.I., McGuirt, W. Vacuum-assisted closure: a new method for wound control and treatment. Animal studies and basic foundation. Plast Surg. 1997; 38: 553-562.
107. Lorée, S., Dompmartin, A., Penven, K. et al. Is vacuum-assisted closure a valid technique for debriding chronic leg ulcers? J Wound Care. 2004; 13: 249-252.
108. Saxena, V., Hwang, C.W., Huang, S. et al. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg. 2004; 114: 1086-1096.
109. Armstrong, D.G., Lavery, L.A., Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005; 366: 9498, 1704-1710.
110. Blume, P.A., Walters, J., Payne, W. et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008; 31: 631-636.
111. Mouës, C.M., van den Bemd, G.J., Heule, F., Hovius, S.E. Comparing conventional gauze therapy to vacuum-assisted closure wound therapy: a prospective randomised trial. J Plast Reconstr Aesthet Surg. 2007; 60: 672-681.
112. Wanner, M.B., Schwarzl, F., Strub, B. et al. Vacuum-assisted wound closure for cheaper and more comfortable healing of pressure sores: a prospective study. Scand J Plast Reconstr Surg Hand Surg. 2003; 37: 28-33.
113. Timmers, M.S., Graafland, N., Bernards, A.T. et al. Negative pressure wound treatment with polyvinyl alcohol foam and polyhexanide antiseptic solution instillation in posttraumatic osteomyelitis. Wound Repair Regen. 2009; 17: 278-286.
114. Stannard, J.P., Volgas, D.A., Stewart, R. et al. Negative pressure wound therapy after severe open fractures: a prospective randomized study. J Orthop Trauma. 2009; 23: 552-557.
115. Braakenburg, A., Obdeijn, M.C., Feitz, R. et al. The clinical efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of acute and chronic wounds: a randomized controlled trial. J Plast Reconstr Surg. 2006; 118: 390-397.
116. Wu, S.C., Armstrong, D.G. Clinical outcome of diabetic foot ulcers treated with negative pressure wound therapy and the transition from acute care to home care. Int Wound J. 2008; 5 (Suppl. 2): 10-16.
117. Ensing, G.T., Roeder, B.L., Nelson, J.L. et al. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo. J Appl Microbiol. 2005; 99: 443-448.
118. Ensing, G.T., Neut, D., van Horn, J.R. et al. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria, an in vitro study with clinical strains. J Antimicrob Chemother. 2006; 58: 1287-1290.
119. Voigt, J., Wendelken, M., Driver, V., Alvarez, O.M. Low-frequency ultrasound (20-40kHz) as an adjunctive therapy for chronic wound healing: a systematic review of the literature and meta-analysis of eight randomized controlled trials. Int J Low Extrem Wounds. 2011; 10: 190-199.
120. Tan, J., Abisi, S., Smith, A., Burnand, K.G. A painless method of ultrasonically assisted debridement of chronic leg ulcers: a pilot study. Eur J Vasc Endovasc Surg. 2007; 33: 234-238.
121. Webster, D.F., Pond, J.B., Byson, M., Harvey, W. The role of cavitation in the in vitro stimulation of protein synthesis in human fibroblasts by ultrasound. Ultrasound Med Biol. 1978; 4: 343-351.
122. Nyborg, W.L. Ultrasonic microstreaming and related phenomena. Br J Cancer. 1982; 45: 156-160.
123. Johns, L.D. Nonthermal effects of herapeutic ultrasound the frequency resonance hypothesis. J Athl Train. 2002; 37: 293-299.
124. Ennis, W.J., Valdes, W., Gainer, M., Meneses, P. Evaluation of clinical effectiveness of MIST ultrasound therapy for the healing of chronic wounds. Adv Skin Wound Care. 2006; 19: 437-446.
125. Ramundo, J., Gray, M. Is ultrasonic mist therapy effective for debriding chronic wounds? J Wound Ostomy Continence Nurs. 2008; 35: 579-583.
126. Lebrun, E., Tomic-Canic, M., Kirsner, R.S. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen. 2010; 18: 433-438.
127. Brigido, S.A. The use of an cellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J. 2006; 3: 181-187.
128. Zeitani, J., Bertoldo, F., Bassano, C. et al. Superficial wound dehiscence after median sternotomy: surgical treatment versus secondary wound healing. Ann Thoracic Surg. 2004; 77: 672-675.
129. Al-Arabi, Y.B., Nader, M., Hamidian-Jahromi, A.R., Woods, D.A. The effect of the timing of antibiotics and surgical treatment on infection rates in open long-bone fractures: A 9-year prospective study from a district general hospital. Injury. 2007; 38: 900-905.
130. Haycocks, S., Chadwick, P. Sharp debridement of diabetic foot ulcers and the importance of meaningful informed consent. Wounds UK. 2008; 4: 51-56.
131. Cardinal, M., Eisenbud, D.E., Armstrong, D.G. et al. Serial surgical debridement: A retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen. 2009; 17: 306-311.
132. Williams, D., Enoch, S., Miller, D. et al. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: A concurrently controlled, prospective cohort study. Wound Repair Regen. 2005; 13: 131-137.
133. Steed, D.L., Attinger, C., Brem, H. et al. Guidelines for the prevention of diabetic ulcers. Wound Repair Regen. 1996; 16: 169-174.
134. Lewis, R., Whiting, P., ter Riet, G. et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess. 2001; 5: 14, 1-131.
135. Ragnarson Tennvall, G., Apelqvist, J., Eneroth, M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 2000; 18: 225-238.
136. Ragnarson Tennvall, G., Apelqvist, J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004; 39 (Suppl. 2): S132-139.
137. Apelqvist, J., Ragnarson Tennvall, G., Persson, U. et al. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Int Med. 1994; 235: 463-471.
138. Prompers, L., Huijberts, M., Apelqvist, J. et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the EURODIALE study. Diabetologia. 2007; 50: 18-25.
139. Prompers, L., Huijberts, M.S.P., Schaper, N.C. et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study, Diabetologia. 2008; 51: 1826-1834.
140. Ballard-Krishnan, S., van Rijswijk, L., Polansky, M. Pressure ulcers in extended care facilities: report of a survey. J Wound Ostomy Continence Nurs. 1994; 21: 4-11.
141. Olin, J.W., Beusterien, K.M., Childs, M.B. et al. Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med. 1999; 4: 1-7.
142. Kerstein, M.D., Gemmen, E., van Rijswijk, L. et al. Cost and cost effectiveness of venous and pressure ulcer protocols of care. Dis Manage Health Outcomes. 2005; 9: 651-663.
143. Posnett, J., Gottrup, F., Lundgren, H., Saal, G. The resource impact of wounds on health-care providers in Europe. J Wound Care. 2009; 18: 154-161.
144. Boulton, A.J.M., Vileikyte, L., Ragnarson Tennvall, G., Apelqvist, J. The global burden of the diabetic foot disease. Lancet. 2005; 336: 1719-1724.
145. Persson, U., Willis, M., Ödegaard, K., Apelqvist, J. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex). A care model with an application using Swedish cost data. Value Health. 2000; 3 (Suppl. 1): 39-46.
146. Margolis, D.J., Gross, E.A., Wood, C.R., Lazarus, G.S. Planimetric rate of healing in venous ulcers of the leg treated with pressure bandage and hydrocolloid dressing. J Am Acad Dermatol. 1993; 28: 418-421.
147. Falanga, V., Saap, L.J., Ozonoff, A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006; 19: 383-390.
148. Ragnarson Tennvall, G., Hjelmgren, J. Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom. Wound Repair Regen. 2005; 13: 13-18.
149. Gottrup, F., Appelqvist, J., Price, P. Outcomes in controlled and comparative studies on non-healing wounds: Recommendations to improve the quality of evidence in wound management. J Wound Care. 2010; 19: 237-268.
150. Posnett, J., Franks, P.J. The costs of skin breakdown and ulceration in the UK. In: Pownall, M. (ed). Skin Breakdown - The Silent Epidemic. Smith & Nephew Foundation, 2010.
151. Oien, R.F., Ragnarson Tennvall, G. Accurate diagnosis and effective treatment of leg ulcers reduce prevalence, care time and costs. J Wound Care. 2006; 15: 259-262.
152. Drummond, M.F., Schulpher, M.J., Torrance, G.W. et al. Methods for the economic evaluation of health care programmes (3rd edn). Oxford University Press, 2005.
153. Granick, M., Boykin, J., Gamelli, R. et al. Toward a common language: surgical wound bed preparation and debridement. Wound Repair Regen. 2005; 14 (Suppl. 1): 1-10.
154. Mosti, G., Iabichella, M.L., Picerni, P. et al. The debridement of hard to heal leg ulcers by means of a new device based on Fluidjet technology. Int Wound J. 2005; 2: 307-314.
155. Mulder, G.D. Cost-effective managed care: gel versus wet-to-dry for debridement. Ostomy Wound Manage. 1995; 41: 2, 68-74.